G. ŞİRİN Et Al. , "Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.," 23rd Annual Conference of APASL , Brisbane, Australia, 2014
ŞİRİN, G. Et Al. 2014. Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.. 23rd Annual Conference of APASL , (Brisbane, Australia).
ŞİRİN, G., Şentürk, Ö., ÇELEBİ, A., & HÜLAGÜ, S., (2014). Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions. . 23rd Annual Conference of APASL, Brisbane, Australia
ŞİRİN, GÖKTUĞ Et Al. "Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.," 23rd Annual Conference of APASL, Brisbane, Australia, 2014
ŞİRİN, GÖKTUĞ Et Al. "Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.." 23rd Annual Conference of APASL , Brisbane, Australia, 2014
ŞİRİN, G. Et Al. (2014) . "Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.." 23rd Annual Conference of APASL , Brisbane, Australia.
@conferencepaper{conferencepaper, author={GÖKTUĞ ŞİRİN Et Al. }, title={Is there any difference between PEG-IFN a2a or a2b plus ribavirin for HCV patient in real life conditions.}, congress name={23rd Annual Conference of APASL}, city={Brisbane}, country={Australia}, year={2014}}